Andrew Allen, Gritstone CEO (Gritstone via website)
August 17, 2021 07:29 AM EDTUpdated 10:35 AM
Coronavirus

Covid-19 roundup: CEPI in­jects $20.6M in­to Grit­stone's push for a next-gen vac­cine; Quali­gen shelves its Covid-19 can­di­date af­ter a failed IND

Nicole DeFeudis

Editor

As the Delta vari­ant dri­ves a glob­al surge in Covid-19 cas­es, the Coali­tion for Epi­dem­ic Pre­pared­ness In­no­va­tions (CEPI) is in­vest­ing …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

Blue­bird bio to sell to in­vest­ment funds af­ter strug­gling to make mon­ey from gene ther­a­pies

CBER's deputy di­rec­tor de­parts as staff shake­up con­tin­ues

Eli Lil­ly stock­piles $548M of oral weight loss drug ahead of launch

FDA ap­proves first drug to treat ul­tra-rare lipid stor­age dis­ease

FDA says Ozem­pic, We­govy short­age is over

sponsored

How AI can ad­dress on­go­ing chal­lenges in the life sci­ences in­dus­try

A service from the Financial Times